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Background: Reports of major limb defects after prenatal cannabis exposure (PCE) in animals and of human
populations in Hawaii, Europe and Australia raise the question of whether the increasing use of cannabis in USA
might be spatiotemporally associated with limb reduction rates (LRR) across USA.
Methods: Congenital anomaly data was from the National Birth Defects Prevention Network, drug use data was
taken from the National Survey of Drug Use and Health (NSDUH), cannabinoid concentration was estimated from
Federal seizure data and ethnicity and income data were from the US Census bureau. Geotemporospatial analysis
was conducted in R.
Results: 436 LRR datapoints were obtained. LRR was significantly associated with cannabis use and tetrahy
drocannabinol (THC) exposure and demonstrated prominent cannabis-use quintile effects. A sharp increase in
LRR occurred from the fourth to fifth quintiles of cannabis exposure (mean ± S.E.M 3.78 ± 0.38 to 6.66 ± 0.56/
10,000 live births, P = 5.22 × 10− 9). In final lagged geospatial models adjusted for ethnicity and income
interactive terms including cannabinoids were highly significant and robust to adjustment. States in which
cannabis was not legalized had a lower LRR (4.28 v 5.01/10,000 live births, relative risk reduction = − 0.15,
(95%C.I. − 0.25, − 0.02), P = 0.021). Internationally 37–63% of cases are estimated to not be born alive. Their
inclusion in these analyzes uniformly intensified the identified effects and the significance of the effect of the
cannabis legalization paradigm rose from P = 0.0256 to P = 0.0146 to P = 0.0048 with silent factors of 0%, 36%
and 63%, respectively.
Conclusion: Therefore a spatiotemporal and dose-dependent association between several cannabinoids including
THC and cannabigerol and LRR is reported, is robust to adjustment, is consistent with pathophysiological and
preclinical studies, accords with findings elsewhere, is markedly exacerbated in higher exposure quintiles, is
exacerbated by cannabis legalization and evidences dose-related intergenerational sequaelae.

1. Introduction
Limb reductions (LR) are rare and dramatic defects which were first
described several thousand years ago in the literature of antiquity
(Bermejo-Sanchez et al., 2011b, 2011a). More recently they received
prominence as the hallmark and initial indication of the teratogenic
action of the drug thalidomide (Bermejo-Sanchez et al., 2011b, 2011a).
LR includes both absence of proximal limb elements (intercalary seg
ments, phocomelia) as well as complete limb absence (amelia). LR oc
curs at a mean rate of 4.20/10,000 live births. Given that Centres for

Disease Control (CDC) data indicate 3791,715 US births in 2018 this
suggests over 1600 LR cases annually across USA (CDC, Centers for
Disease Control et al., 2019). Leading studies from the International
Clearing House of Birth Defects Surveillance and Research (ICBDSR)
noted that little was known about the causes of these disorders
(Bermejo-Sanchezet al. 2011b, 2011a). Sometimes LR arise as part of
exceedingly rare congenital syndromes or together with multiple
congenital anomalies, however their most common presentation is as an
isolated disorder. ICBDSR noted that intrauterine vascular catastrophes
have been shown to cause some cases with clear evidence of placental
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arteritis, vascular inflammation, subacute thrombosis and vascular and
placental fibrosis seen in some cases (Hoyme et al., 1982; Bermejo-
Sanchez et al., 2011b, 2011a). The upper limbs are known to be affected
about twice as often as the lower. On the basis of minimal family in
heritance isolated LR is not thought to have a genetic basis. Hotspots for
both phocomelia and amelia have been reported, particularly in Victo
ria, Australia (Bermejo-Sanchez et al., 2011b, 2011a). It should be noted
that not all cases are born alive. This is important as most registries list
the numbers of cases as rates per 10,000 live births so that cases which
occur as still births and cases for which Early Termination of Pregnancy
For the Anomaly (ETOPFA) is performed can account for 37–63% of the
total numbers as described below. This becomes an important issue
analytically.
The embryology of limb development is complex and fascinating
with limbs developing along each of the three spatial axes as a complex
interplay of transcription factor and inducer gradients and an ordered
and sequential cascade of molecular and signaling events. The emer
gence of the limb vessel which supplies the emerging structure is central
to the maintenance of the whole process. It therefore becomes easy to
understand how environmental impacts at critical stages could severely
impact this sophisticated and coordinated sequential process.
Similarly sonic hedgehog is a key body morphogen which is critically
involved in the formation of most body systems and plays multiple
critical roles in limb bud initiation and pattern formation of the prox
imal, middle and distal (phalanges) limb from the 24th day of gestation
(Carlson, 2019). It was recently shown to be inhibited by many canna
binoids (Fish et al., 2019).
A remarkably prescient paper from Hawaii found a greatly elevated
rate of upper limb reduction deformity amongst patients exposed to
cannabis either together with other drugs, or by itself (Forrester and
Merz, 2007). On the basis of 7 and 3 cases exposed amongst 115 total
cases, rate ratios of 23.27 (95%C.I. 9.15–49.50) and 21.90 (4.45–65.63)
were reported. Our hypothesis that rates of LR have a positive associa
tion with cannabis use was based on the previous Hawaiian findings and
was formulated prior to the commencement of this work. Since both
drug use and birth defect data was available for USA that nation formed
our study setting.

2.2. Derived variables

2. Methods

Key data including software code in R and a Data Dictionary key has
been made available in the Mendeley data repository at this URL:
https://doi.org/10.17632/gtk7w24yvs.1 .

Quintiles were calculated based on the interval rather than the
population distribution and were calculated with the cut_interval func
tion from ggplot2 in R. SAMHSA report different rates of intensity of
cannabis use by days used last month by ethnicity at the national level.
These data were used to calculate mean numbers of days cannabis was
smoked. This figure was multiplied by the state cannabis use rate and the
THC potency of cannabis in that year to derive a state based cannabis
ethnic index referred to in the Tables as an ethnic “score.” The last
month cannabis use rates, abbreviated to “mrjmon” in NSDUH, was
multiplied by the cannabinoid concentration to derive an estimate of
state-based levels of exposure to individual cannabinoids.
2.3. Statistics
Data was processed in “R-Studio” 1.2.1335 based on “R” 3.6.1 from
Comprehensive R-Archive Network (CRAN). Variables were log trans
formed guided by the Shapiro test. Data were manipulated and matched
in R-package dplyr (Wickham et al., 2019), graphs were drawn in
ggplot2 (Wickham et al., 2019), maps were drawn in sf (Pebesma, 2018)
and ggplot2, geofacetting was done with geofacet (Hafen, 2020), linear
regression was performed in base, mixed effects regression with State as
the random variable was ocnducted using R package nlme (Pinheiro
et al., 2020), panel regression was performed in plm (Croissant et al.,
2014), two-step regression was performed in AER (Kliber and Zeileis,
2008), spatial weights were prepared in spdep (Bivand et al., 2007) and
spatial regression was performed in splm (Millo and Piras, 2012; Millo
and Piras, 2018). For linear and panel regression missing data was
casewise deleted. For spatial regression missing data was imputed by
temporal kriging (mean substitution) as described. LR datapoints more
than 10 standard deviations from the mean were dropped. P< 0.05 was
considered significant.
Inverse probability weights (IPW) were calculated on the balanced
kriged data using the ipw package in R (Van der Wal and Geskus, 2011).
2.4. Data sharing statement

2.1. Data
Birth defect data was extracted from the annual reports of National
Birth Defect Prevention Network organized by Centers for Disease
Control Atlanta Georgia (National Birth Defects Prevention Network,
2018). These reports are a collation of reports from state-based birth
defects registries and usually (with a few exceptions) report the data in
five year moving average style. The central year of this period was taken
as the nominal year of the report. Data on the annual number of births in
each state was extracted from the CDC Wonder births registries (CDC,
Centers for Disease Control et al., 2019). US Census data for populations,
age distributions, ethnicity and median household income was accessed
from US Census Bureau via tidycensus package from R. Drug use data
was taken from the National Survey of Drug Use and Health (NSDUH)
conducted annually by the Substance Abuse and Mental Health Services
Administration (SAMHSA) (Substance Abuse and Mental Health
Administration, Department of Health and Human Services, 2018).
NSDUH is a survey which is carefully structured to be representative of
the non-institutionalized US adult population. Cannabinoid (Δ9-tetra
hydrocannabinol (Δ9THC), cannabigerol (CBG), cannabichromene,
cannabinol, and cannabidiol) concentrations were taken from those
reported in Federal Seizures by the Drug Enforcement Agency (ElSohly
et al., 2016; Chandra et al., 2019).

2.5. Ethics
This research was approved by the Human Ethics Research Com
mittee of the University of Western Australia June 7th 2019, (RA/4/20/
4724).
3. Results
436 data points relating to LR rate (LRR) were retrieved from NBDPN
from 1986 to 1988 to 2012–2016 as shown in Supplementary Table 1.
Prior to 2007–2011 LRR was listed separately for upper and lower limbs.
After that time all limb defects were grouped under a single heading.
Data from the earlier period were summed to make it comparable with
the data from the later time period. For analytical purposes the middle
year of each quoted time period is considered to be the nominal year of
reference. A datapoint for Oklahoma 2005–2009 was omitted as it lay
beyond 13.7 standard deviations outside the mean. 45 separate states
contributed data to the whole dataset. Many datapoints are absent from
the original data obtained from NBDPN. These data are detailed in
Table 1.
The median (±S.E.M.) LRR over the whole period of the NBDPN
dataset was 4.20 (95%C.I. 2.51, 5.89) / 10,000 live births. The median
figure for 2012–2016 was 4.10 (3.88, 4.31).
This data is presented map graphically in Fig. 1. The absence of many
2
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exposure (Panel C). When these data are charted by quintile of cannabis
use the highest quintile appears to be well above the others (Panel D).
Panel E charts the LRR against cannabis exposure by cannabis use
quintile. The highest quintile appears to be above the others. This is
illustrated in Panel F where the highest quintile is shown compared to
the remainder. Statistical significance is indicated here by failure of the
notches on the boxes to overlap.
The data are analyzed formally with results presented in Supple
mentary Table 3. The time trend is confirmed to not be significant. For
the quintile comparison the comparator quintile is the fourth quintile
which was shown in Fig. 2 to be the quintile with the lowest LRR. A
sharp increase in LRR occurred from the fourth to fifth quintiles of
cannabis exposure (mean±S.E.M 3.78±0.38 to 6.66 ± 0.56, β-est. =
2.88 (1.93, 3.83), P = 5.22 × 10− 9). The monthly cannabis use effect is
significant (β-est. = 8.507 (− 0.040, 17.054), P = 0.0492) and the THC
exposure effect is also highly significant (from β-est. = 10.637 (3.704,
17.569), P = 0.0029).
Fig. 3 presents data graphically looking at the log LRR plotted against
(A) drugs, (B) cannabinoids and (C) ethnicity. There is little relationship
against drug use, with a suggestion of a declining effect with alcohol
abuse or dependence shown in the first panel. Contrariwise with
monthly cannabis use, Δ9THC exposure, cannabichromene, cannabinol
and cannabigerol exposure there is a suggestion of a positive regression
line slope with increasing cannabinoid exposure. The ethnicity plot
shows a falling relationship with Caucasian-American ancestry, but a
rising relationship with Hispanic-American and American Indian /
Alaska Native identification.
The effects with cannabinoids are formalized in Supplementary
Table 4 which shows significant relationships between LRR and Δ9THC,
cannabigerol, cannabichromene and cannabinol.
These data are well suited to panel regression a technique which was
developed within econometrics and which tolerates missing values. The
results are shown in Supplementary Table 5. The top half of this
Table presents regressions done in each domain of socioeconomics,
ethnicity and drug exposure. Median income is confirmed not to be
significant. Non-Hispanic American Indian / Alaska Native ancestry
(NHAIAN) is alone significant amongst the races. When drug exposure,
ethnicity and income are combined in a multivariable additive model
terms including cannabis exposure (from P = 0.0084) and ethnicity are
significant. When the model is lagged to two years only drugs, including
cannabis, are significant.
It was of interest to conduct spatial regression on these data. As
spatial regression algorithms do not permit missing data it became
necessary to impute the missing values. Supplementary Table 6

Table 1
. Baseline demographic and substance exposure characteristics of LRR study
population.
Covariate

Overall

Sample Size
Limb Reduction Rate (median / 10,000 live births [IQR])
Substance Exposure (% Population)
Alcohol Abuse (median% [IQR])
Analgesics (median% [IQR])
Binge Alcohol (median% [IQR])
Cigarettes (median% [IQR])
Cocaine (median% [IQR])
Cannabis (median% [IQR])
Cannabinoid Exposure
THC Exposure (median Units [IQR])
CBD Exposure (median Units [IQR])
CBC Exposure (median Units [IQR])
CBN Exposure (median Units [IQR])
CBG Exposure (median Units [IQR])
Cannabis Exposure Quintiles (Fraction)
Quintile 1 (0.0472, 0.0720)
Quintile 2 (0.0720, 0.0968)
Quintile 3 (0.0968, 0.1220)
Quintile 4 (0.1220, 0.1460)
Quintile 5 (0.1460, 0.1710)
Ethnicities
NHWhite (median% [IQR])
NHBlack (median% [IQR])
Hispanic (median% [IQR])
NHAsian (median% [IQR])
NHAIAN (median% [IQR])
NHNHPI (median% [IQR])
Median Household Income (median $ [IQR])
Legal Status (N (%))
Decriminalized
Illegal
Legal
Medical

435
4.20 [3.20, 5.50]
0.07 [0.07, 0.08]
0.04 [0.04, 0.05]
0.25 [0.23, 0.27]
0.25 [0.23, 0.28]
0.02 [0.01, 0.02]
0.06 [0.05, 0.08]
0.66 [0.52, 0.85]
0.02 [0.01, 0.02]
0.02 [0.01, 0.02]
0.03 [0.02, 0.04]
0.03 [0.02, 0.03]
154 (35.4)
156 (35.9)
65 (14.9)
28 (6.4)
32 (7.4)
0.68 [0.58, 0.80]
0.07 [0.04, 0.15]
0.08 [0.04, 0.14]
0.02 [0.01, 0.04]
0.01 [0.00, 0.01]
0.00 [0.00, 0.00]
46,735 (39,508, 53,867)
79 (18.2)
283 (65.1)
7 (1.6)
57 (13.1)

data points is immediately apparent.
States were divided into quintiles based on their last month cannabis
use rate in the 2017 NSDUH report as shown in Supplementary Table 2.
Quintile 5 was made up of the states of Colorado, Alaska, Vermont,
Puerto Rico and Quintile 4 of Maine, Rhode Island, Oregon, New
Hampshire.
Fig. 2 presents these data in an introductory manner. Panel A pre
sents the LRR data over time. The time-trend appears essentially flat.
Panel B presents it as a function of last month cannabis use. The trend
appears to be rising. Similar results are shown for trend against THC

Fig. 1. Map-graph of the limb reduction rate across USA over time. Raw data plot.
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Fig. 2. Univariate limb reduction trends. A: Trends over time. B. Trends by Cannabis use. C. Trends by THC Exposure. D. Time trends by cannabis use quintile. E:
Limb reduction rates by cannabis use, by cannabis use quintile. F: Boxplot of limb reduction rate by cannabis use quintile. Note jump from fourth to fifth quintile.

Fig. 3. . Univariate exposure plots. Limb reduction rates (raw data) as a function of (A) drug exposure, (B) cannabinoid exposure and (C) census-identified ethnicity.

illustrates this from temporal kriging (mean substitution over time).
Limiting the data to the period 2005–2014, when it was relatively
complete and the drug dataset from NSDUH was also complete, 27
kriged data points (9.3%) were added to the 288 NBDPN dataset to
provide the kriged dataset of N = 315 for spatial analysis. 34 states
contributed data to this dataset.
Fig. 4 shows this kriged data map-graphically. Fig. 5 shows the
neighbor links which were converted into the spatial weights matrix for
the spatial regression.
Table 2 presents the results of the spatial analysis. Instrumental and

lagged variables are shown in the first column of the Table. When
considering ethnicity, Hispanic ethnicity is significant. Median house
hold income (MHY) is not significant. In a combined model with all
three domains, drugs including cannabis (from β-est. = − 4.122 (− 6.760,
− 1.484), P = 0.002) and Hispanic ethnicity are significant.
When an interaction between (estimates of) the cannabinoids
Δ9THC and CBG were used in place of cannabis the results shown in the
lower part of this Table were derived. In an unlagged model Δ9THC
exposure was significant (from β-est. = 0.589 (0.183, 0.995), P = 4.5 ×
10− 3). In a model lagged to four years which better accounts for the
4
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Fig. 4. . Map-graph of the limb reduction rate across USA over time after temporal kriging 2005–2014.

Fig. 5. . Geospatial links and weights. (A) Editing of polynomial-derived spatial links. (B) Final links used in spatial weights matrix.

moving average style of data published by NBDPN, the Δ9THC: CBG
interaction was significant (from β-est. = − 1.606 (− 2.459, − 0.753), P =
2.2 × 10− 4).
Supplementary Tables 7 and 8 perform a similar role for the LRR at
lags 36% and 63%, respectively. It is noted that the significance of the
cannabis related terms rises with the rising silent factor.
Supplementary Table 9 re-formats data from the tables in the ICBDSR
references limiting consideration to only registries reporting positive
values for ETOPFA or stillbirths (SB), a procedure suggested by leading
public health schools (Mokdad et al., 2017; Roth et al., 2017; Dwyer-
Lindgren et al., 2018). It shows that 37% of cases from the US registries
from Texas, Georgia and Utah were not accounted for in live birth fig
ures. Worldwide the equivalent figure was 63%. This combined ETOP
FA+SB figure may be considered as an important “hidden factor” or
“silent factor” behind the present dataset analysis.

It is conceivable that the type of case finding conducted by the state
registries might impact case rates. Interestingly case rates in registries
with passive case rates were higher than those in registries practicing
active or mixed case finding. Compared to passive case finding active
and mixed case finding were associated with rate reduction (β-estimate
= − 0.27 (− 0.41, − 0.14), P = 0.0001 and − 0.16 (− 0.360, − 0.33), P =
0.0152; model Adj. R2 = 0.0846, F = 7.935, df = 2148, P = 0.0005).
Fig. 6A presents all of the official NBDPN data on the ethnic rates of
LR. Many zeroes are entered in the data, doubtless most of them
meaninglessly or due to low number counts. However low rates are not
zero rates as well argued by University of Washington researchers
(Mokdad et al., 2017; Roth et al., 2017; Dwyer-Lindgren et al., 2018).
Following their approach we therefore omit the zeros. Fig. 6B shows that
this method brings out the high rates in the Non-Hispanic American
Indian / Alaska Native (NHAIAN) group. There is no significant trend
5
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Table 2
. Geospatial spreml regression of LRR on drugs, cannabinoids, race and income.
Instrumental ± Lagged Variables

NHWhite_THCExposure
NHBlack_THCExposure
NHAIAN_THCExposure
Hispanic_THCExposure
NHAsian_THCExposure

Δ9THC_Exposure
Cannabigerol_Exposure

THC_Exposure
CBG_Exposure
NHWhite_THCExposure
NHBlack_THCExposure
NHAIAN_THCExposure
Hispanic_THCExposure
NHAsian_THCExposure
THC_Exposure
CBG_Exposure
NHWhite_THCExposure
NHBlack_THCExposure
NHAIAN_THCExposure
Hispanic_THCExposure
NHAsian_THCExposure
THC_Exposure, 0:2
CBG_Exposure, 0:2
NHWhite_THCExposure, 0:2
NHBlack_THCExposure, 0:2
NHAIAN_THCExposure, 0:2
Hispanic_THCExposure, 0:2
NHAsian_THCExposure, 0:2
THC_Exposure, 0:4
CBG_Exposure, 0:4
NHWhite_THCExposure, 0:4
NHBlack_THCExposure, 0:4
NHAIAN_THCExposure, 0:4
Hispanic_THCExposure, 0:4
NHAsian_THCExposure, 0:4

Parameters
Parameter

Estimate (C.I.)

P-Value

Races
spreml(LR_Rate ~ NHWhite + NHBlack + Hispanic + NHAsian + NHAIAN)
Hispanic
0.12 (0.00, 0.24)
0.0471

Income
plm(LR_Rate ~ Median.HH.Income)
Median.HH.Income

0.00 (0.00, 0.00)

0.7443

0 Lags
spreml(LR_Rate ~ Cigarettes * Cannabis * Analgesics + Alcohol.Abuse + Cocaine)
Cigarettes: Cannabis
− 1.04 (− 1.98, − 0.10)
0.0293
Cigarettes: Cannabis: Analgesics
− 0.34 (− 0.63, − 0.05)
0.0253

Model
LogLik

Parameters

Value

P-Value

phi
psi
rho
lambda

3.4769
0.7275
− 0.0896
− 0.0650

0.0026
<2.0E-16
0.5083
0.6345

phi
psi
rho
lambda

3.9708
0.7258
− 0.0567
− 0.0830

0.0007
<2.0E-16
0.6749
0.5479

phi
psi
rho
lambda

0.0065
0.9565
0.0301
− 0.2218

0.0015
<2.0E-16
0.6944
0.5091

All Variables
0 Lags
spreml(LR_Rate ~ Cigarettes * Cannabis * Alcohol.Abuse + Analgesics + Cocaine + MHY + 5_Races)
Cigarettes: Cannabis
− 4.12 (− 6.77, − 1.47)
0.0022
phi
3.3295
0.0992
Cigarettes: Cannabis: Analgesics
− 2.27 (− 3.98, − 0.56)
0.0087
psi
0.7423
<2.0E-16
Cannabis: Analgesics
0.26 (0.04, 0.48)
0.0185
rho
− 0.1138
0.3730
Hispanic
0.14 (0.02, 0.26)
0.0259
lambda
− 0.0565
0.6572
Cigarettes: Analgesics
− 2.59 (− 5.08, − 0.10)
0.0410
0 Lags - Cannabinoids
spreml(LR_Rate ~ Cigarettes * THC_Exposure * Cannabigerol_Exposure * Alcohol.Abuse + Analgesics + Cocaine + MHY + 5_Races)
THC_Exposure: Analgesics
0.59 (0.18, 1.00)
0.0045
73.1187
phi
3.5723
0.0005
Cigarettes: CBG_Exposure
− 6.65 (− 11.43, − 1.87)
0.0064
psi
0.7548
<2.0E-16
Cigarettes: THC_Exposure: Analgesics
− 2.17 (− 3.74, − 0.6)
0.0065
rho
− 0.0265
0.8352
Cigarettes: CBG_Exposure: Analgesics
− 0.33 (− 0.57, − 0.09)
0.0068
lambda
− 0.1140
0.3777
CBG_Exposure
1.55 (0.33, 2.77)
0.0118
Cigarettes
− 18.58 (− 34.16, − 3.00)
0.0195
2 Lags - Cannabinoids
spreml(LR_Rate ~ Cigarettes * THC_Exposure * Cannabigerol_Exposure * Alcohol.Abuse + Analgesics + Cocaine + MHY + 5_Races)
Hispanic
0.12 (0, 0.24)
0.0383
10.8625
phi
1.9556
0.2548
psi
0.7141
0.0001
rho
− 0.1751
0.3577
lambda
0.0595
0.7522
4 Lags - Cannabinoids
spreml(LR_Rate ~ Cigarettes * THC_Exposure * Cannabigerol_Exposure * Alcohol.Abuse + Analgesics + Cocaine + MHY + 5_Races)
Cigarettes: THC_Exposure: CBG_Exposure
− 1.61 (− 2.47, − 0.75)
0.00022
16.28796
phi
0.0149
NA
Cigarettes: CBG_Exposure
− 9.81 (− 15.3, − 4.32)
0.0005
psi
0.9700
<2.0E-16
Cigarettes: CBG_Exposure: Analgesics
− 2.96 (− 4.68, − 1.24)
0.0008
rho
0.0291
0.9043
THC_Exposure: Analgesics
0.38 (0.14, 0.62)
0.0010
lambda
− 0.2131
0.3512
Analgesics
− 2.07 (− 3.42, − 0.72)
0.0026

Abbreviations:.
MHY:- Median Household Income.
Median.HH.Income:- Median Household Income.
NHWhite:- Non-Hispanic Caucasian-American.
NHBlack:- Non-Hispanic African-American.
NHAsian:- Non-Hispanic Asian-American.
NHAIAN:- Non-Hispanic American Indian / Alaskan Native.
Technical Notes:.
phi:- Idiosyncratic component of the spatial error term.
psi:- Individual time-invariant component of the spatial error term.
rho:- Spatial autoregressive parameter.
lambda:- Spatial autocorrelation coefficient.

< 2.2 × 10− 16, and β-est. = 0.449 (0.357, 0.541), P < 2.2 × 10− 16).
However when the days of use of cannabis by each ethnicity and the
THC potency of the cannabis smoked are used as interactive instru
mental variables this effect completely disappears. When the full com
plement of instrumental variables is employed in the exhaustive model
only the NHAIAN group is significant.
This important result shows that whilst racial factors are apparently

with time. When the data are adjusted for the US and international
hidden factors the appearances shown in Fig. 6C,D are revealed.
Supplementary Table 10 presents two-step regression results per
formed in R::AER using the Asian / Pacific Islander group as the controls
and the unadjusted LRR as the dependent variable. Very highly signifi
cant results are shown with the effects for NHAIAN and Non-Hispanic
African-Americans significant (from β-est. = 0.999 (0.885, 1.113), P
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Fig. 6. Limb reduction rates by ethnic background (NBDPN data). (A) Limb reduction rates over time by ethnicity. (B) Limb reduction rates by ethnicity over time
omitting uninformative zero’s from data. (C) Same as (B) but adjusted for US “silent case” rate (37%) arising from ETOPFA’s and stillbirths. (D) Same as (B) but
adjusted for global “silent case” rate (63%) arising from ETOPFA’s and stillbirths.

interaction (β-estimate = 0.007 (0.001, 0.0013), P = 0.0396; model R2
= 0.0139, F = 4.055, df = 2, 432, P = 0.0180).
Table 4A presents the increased relative risk (RR) associated with
cannabis legalization and Table 3B presents the relative risk reduction
associated with non-cannabis legalized status. As can be seen in
Table 4A the elevated RR of LRR is 1.17 (1.02, 1.34) . The table also
presents attributable risks in the exposed, attributable risks in the pop
ulation and applicable P-values. Table 4B presents the inverse of these
results as relative risk reductions (RRR).
The kriged dataset lends itself to inverse probability weighted mixed
effects regression. This was conducted and the results shown in Table 5.
As shown in this Table terms including cannabis or cannabinoids are
significant and appear in final models in the additive, four-way
cannabis, and five-way cannabinoid models from very high levels of

strong, they are completely accounted for by substance and particularly
cannabinoid exposure and are thus not robust to adjustment.
Fig. 7 presents the effects of cannabis legalization policies on LRR.
The legalized status appears to have a higher LRR than comparators.
Panel B dichotomizes the legal status into legalized status compared
to the others.
Table 3 presents the results of linear regression of the legal status
over time for the three situations with silent factors of 0%, 37% and
63%, respectively. The significance of the higher rate under the legal
paradigm is noted to increase along with the applicable silent factor.
Supplementary Table 11 presents the numbers of cases and controls
in each of the legal categories dichotomized to legal states vs. others. At
linear regression the LRR was found to be significantly greater in states
where cannabis was legal as a function of the time: legal status

Fig. 7. . Limb reduction rates by (A) cannabis legal status and (B) cannabis legal status dichotomized into legalized vs. other legal statuses. Data not corrected for
silent factors.
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Table 3
. Linear regression of legal status.
Model & Silent Factor

Term

Parameters
Estimate (C.I.)

t-statistic

P-Value

0%

Year
Illegal Status
Legal Status
Medical Status
Year
Illegal Status
Legal Status
Medical Status
Year
Illegal Status
Legal Status
Medical Status

− 0.02 (− 0.05, 0)
0.22 (− 0.23, 0.67)
1.58 (0.19, 2.96)
− 0.05 (− 0.66, 0.56)
0.05 (0.02, 0.09)
0.32 (− 0.32, 0.95)
2.44 (0.48, 4.4)
− 0.11 (− 0.97, 0.76)
0.22 (0.18, 0.27)
0.37 (− 0.59, 1.32)
4.25 (1.31, 7.2)
− 0.24 (− 1.54, 1.06)

− 2.05
0.968
2.24
− 0.173
3.36
0.98
2.45
− 0.246
9.22
0.749
2.84
− 0.365

0.0415
0.3330
0.0256
0.8630
0.0009
0.3280
0.0146
0.8060
1.47E-18
0.4540
0.0048
0.7150

37%

63%

Model
Adj. R-Squared

F

Deg. Freedom

P-Value for Model

0.0168

2.812

4421

0.0252

0.0346

4.811

4421

0.0008

0.1892

25.79

4421

3.93E-19

Table 4
. Relative Risk Calculations for: (A) Risk Elevation by Legal Status and (B) Risk Reduction by Not Legal Status.
Incr RR

AFE

AFP

P-values

Legal_States
215
428,805
429,020
0.0005
Others
14,398
33,630,778
33,645,176
0.0004
(B) Relative Risk Reduction Accompanying Absence of Cannabis Legalization
LR+
LRTotal
Risk

LR+

1.17 (1.02 to 1.34)

14.61 (2.30 to 25.36)

0.21 (0.02 to 0.41)

0.0212

RRR

AFE

AFP

P-values

Others
Legal_States

0.15 (0.02 to 0.25)

− 17.11 (− 33.98 to − 2.36)

− 16.85 (− 33.43 to − 2.34)

0.0212

14,398
215

LR-

33,630,778
428,805

Total

33,645,176
429,020

Risk

0.0004
0.0005

Abbreviations.
LR+- Limb Reductions.
LR– No Limb Reductions (Otherwise normal births).
Incr- Increased.
RR- Relative Risk.
RRR- Relative Risk Reduction.
AFE- Attributable Fraction in Exposed.
AFP- Attributable Fraction in Population.

statistical significance.

number of other EU counties allow cannabinoids to enter the food chain
as cattle and stock fodder whereas Switzerland does not allow this
practice. Public health enquiries in this regard are on-going. Nearby
Switzerland has not seen any such increase in cases.

4. Discussion
4.1. Statement of principal findings

4.3. Possible explanations for study findings

The key results of the study were that LRR was significantly associ
ated with cannabis use, and in a geospatiotemporal context with expo
sure to the cannabinoids Δ9THC and cannabigerol, although there was
no time trend. Moreover these changes were robust to adjustment for
common sociodemographic covariates including socioeconomic and
ethnographic factors. There was a marked quintile effect with a sharp
jump from the fourth to fifth quintile (P = 5.22 × 10− 9). The strong
effects of ethnic background were completely dissipated by adjustment
for cannabinoid exposure. 40–60% of the cases are not accounted for in
live birth rates. Importantly the legal paradigm relating to cannabis
regulation was shown to be highly significant with a relative risk
reduction (RRR) of 15% (95%C.I. 0.02 to 0.25) for states where cannabis
had not been legalized

Various mechanistic pathways exist to underpin the geospatial and
causal epidemiological results reported in this study. Cannabis can act
by several cellular mechanisms to restrict cell growth and inhibit cell
division (McClean and Zimmerman 1976; Zimmerman and Raj, 1980;
Tahir and Zimmerman, 1991) and can act genomically and epigenomi
cally (Zimmerman and Zimmerman, 1987; Zimmerman and Zimmer
man, 1990). Its mitochondrial inhibitory actions (Bartova and
Birmingham, 1976; Hebert-Chatelain et al., 2014; Wolff et al., 2015;
Hebert-Chatelain et al. 2016) carry serious downstream genotoxic and
epigenotoxic implications by reducing cellular energy charge for
DNA-dependent reactions (Canto et al., 2015), by limiting the avail
ability of numerous chemical moieties which underpin epigenomic
regulation and by inducing mitonuclear stress response cascade (Canto
et al., 2015). Cannabinoid receptors exist at high density on vascular
endothelium (Yamaji et al., 2003; van Diepen, Schlicker et al. 2008;
Bukiya et al., 2014; Gasperi et al., 2014; Pacher et al., 2018) and can
induce arteritis (Pacher et al., 2018) be pro-coagulant and
anti-prostacyclin (Wang et al., 2011; Murphy et al., 2018) and have been
associated with human vascular aging (Reece et al., 2016). Moreover it
has been linked with gastroschisis in many studies (Reece and Hulse,
2019a, 2019b) which is a congenital defect now considered to have a
vasculopathic basis (Hoyme et al., 1981; Van Allen and Smith, 1981;
Werler et al., 2009; Lubinsky, 2014). These data imply that cannabis
could be acting via the vasculopathic pathway outlined in the

4.2. Consistency with other reports
Our results are supported by the prior results from Hawaii (Forrester
and Merz, 2007) and also apparently by reports from German obstetric
hospitals and French birth defect registries where outbreaks of LR have
been described (Agence France-Presse in Paris, 2018; Willsher, 2018;
Robinson, 2019). The odds ratio reported in France was 58-times
elevation (Agence France-Presse in Paris, 2018; Willsher, 2018) which
is within the confidence interval reported from Hawaii (95%C.I. 4.45,
65.63). Similarly French cows in these areas are more frequently born
without forelimbs. Interestingly, both France and Germany along with a
8
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Table 5
. Inverse probability-weighted mixed effects regression – final models.
Parameter
Parameter
Additive
Afric.Am.THC.Exposure
Alcohol.Abuse
Cigarettes
Cauc.Am
Afric.Am
Cocaine
Asian.Am
Analgesics
Median.HH.Income
Hispanic.Am
4-Way Interactions with Cannabis
Cauc.Am.THC.Exposure
Asian.THC.Exposure
Cigarettes: Analgesics
Cigarettes
Cauc.Am
Cigarettes: Cannabis: Analgesics
Cigarettes: Cannabis
Alcohol.Abuse: Analgesics
Alcohol.Abuse
Alcohol.Abuse: Cannabis: Analgesics
Alcohol.Abuse: Cannabis
Cigarettes: Alcohol.Abuse: Cannabis
Cannabis
Cigarettes: Alcohol.Abuse: Cannabis: Analgesics
Cannabis: Analgesics
Cigarettes: Alcohol.Abuse
Cigarettes: Alcohol.Abuse: Analgesics
Analgesics
Afric.Am
Asian.Am
Median.HH.Income
Afric.Am.THC.Exposure
5-Way Interactions with Cannabinoids
Cauc.Am.THC.Exposure
Asian.THC.Exposure
Cigarettes: THC.Exposure: Cannabigerol.Exposure
Analgesics
Cigarettes: THC.Exposure
Alcohol.Abuse: THC.Exposure: Cannabigerol.Exposure
Alcohol.Abuse: THC.Exposure
Cigarettes: Cannabigerol.Exposure
Cigarettes
Cauc.Am
Alcohol.Abuse: Cannabigerol.Exposure
Alcohol.Abuse
Cannabigerol.Exposure
Cigarettes: Alcohol.Abuse
Cigarettes: Alcohol.Abuse: Cannabigerol.Exposure
THC.Exposure
Cigarettes: Alcohol.Abuse: THC.Exposure
THC.Exposure: Cannabigerol.Exposure
Cigarettes: Alcohol.Abuse: THC.Exposure: Cannabigerol.Exposure
Asian.Am
Hispanic.Am
Afric.Am.THC.Exposure

Model
AIC

BIC

logLik

<0.0001
<0.0001
<0.0001
<0.0001
0.0002
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

2882.746

2930.68

− 1428.373

4.06 (3.7, 4.42)
0.91 (0.83, 0.99)
1621.82 (1233.55, 2010.1)
4946.23 (3744.11, 6148.36)
8.06 (5.71, 10.41)
480.35 (337.18, 623.51)
1462.8 (1017.39, 1908.22)
4086.78 (2807.4, 5366.17)
12,104.21 (8150.79, 16,057.62)
1102.5 (626.32, 1578.68)
3224.18 (1743.59, 4704.78)
− 17,394.37 (− 23,740.4, − 11,048.35)
− 286.85 (− 391.41, − 182.28)
− 5802.53 (− 7852.78, − 3752.27)
− 95.46 (− 128.93, − 62)
− 60,908.76 (− 77,951.49, − 43,866.03)
− 20,233.76 (− 25,770.67, − 14,696.85)
− 336.46 (− 426.72, − 246.2)
− 0.69 (− 0.87, − 0.51)
− 1.16 (− 1.47, − 0.86)
− 1.02 (− 1.13, − 0.91)
− 3.65 (− 4.01, − 3.3)

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

2083.733

2174.869

− 1016.866

8.51 (7.99, 9.03)
1.177 (1.09, 1.27)
465.801 (385, 547.09)
0.559 (0.45, 0.67)
1496.707 (1190, 1805.27)
1352.223 (1070, 1631.66)
4316.283 (3240, 5391.08)
201.087 (130, 272.14)
643.833 (413, 874.77)
8.728 (5.17, 12.29)
569.126 (335, 802.89)
1781.128 (1020, 2541.34)
− 41.58 (− 58, − 25.12)
− 8898.557 (− 12,200, − 5638.91)
− 2807.926 (− 3810, − 1805.22)
− 324.953 (− 399, − 250.66)
− 20,546.282 (− 25,000, − 16,089.52)
− 99.945 (− 119, − 80.66)
− 6441.429 (− 7620, − 5264.54)
− 1.607 (− 1.89, − 1.33)
− 4.5 (− 5.05, − 3.95)
− 6.43 (− 6.83, − 6.03)

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

2083.381

2174.517

− 1016.69

Estimate (C.I.)

P-Value

0.61 (0.57, 0.65)
30.68 (27.6, 33.75)
3.36 (2.97, 3.74)
11.54 (7.29, 15.79)
0.35 (0.16, 0.53)
− 0.17 (− 0.24, − 0.1)
− 1.94 (− 2.27, − 1.61)
− 0.94 (− 1.08, − 0.81)
− 0.96 (− 1.08, − 0.84)
− 7.98 (− 8.39, − 7.57)

Introduction.
Importantly it was recently shown that THC and cannabidiol
amongst other cannabinoids inhibit sonic hedgehog (shh) which is one
of the major human body morphogens involved in the formation and
patterning of numerous human organs and structures during embryonic
life including the limbs (Carlson, 2019; Fish et al., 2019). Cannabinoids
act by forming heterodimers with the molecule patched which is the
downstream multi-molecular effector scaffold of the shh receptor
smoothened and by other mechanisms (Fish et al., 2019). Shh is a key
body morphogen critically involved in specifying the formation and
outgrowth of the developing limb bud and also correct specification of
the digits (Carlson, 2019). In this regard it is notable that the original
report from Hawaii found both syndactyly and polydactyly to be

elevated after prenatal cannabinoid exposure (Forrester and Merz,
2007). In this context it is therefore easy to understand that disruption of
shh signaling during the critical periods of limb formation during em
bryonic life could impede limb development, outgrowth and pattern
formation.
4.4. Absolute and relative strengths and weaknesses of the study
This study has various strengths including its use of populationderived indices such as ethnicity and median household income and a
national birth anomalies dataset. Our study is the first to apply the
analytical techniques of geospatial regression to this topic, and the first
to our knowledge to investigate the impact of drug exposure on this
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major teratological outcome in the geospatial context. Study limitations
are those related to its ecological design. We did not have access to in
dividual case data and were not able to directly correlate exposure with
outcomes. Moreover we did not have access to fine geospatial resolution
birth defect data such as was recently published by CDC (Short et al.,
2019). In view of the public health importance of the issue and the
numbers of exposed individuals we feel that the area needs further
research at both the basic sciences and finer spatial epidemiological
level.
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4.5. Generalizability
In that the USA is the world’s leading nation on many metrics and
provides the best publicly available data on both drug exposure and
birth defects, we feel that the present findings are likely to be general
izable to similar contexts in other nations wherever the data is of suf
ficient quality to make reliable assessments.
4.6. Implications for policy and future directions
Our interpretation of these results is that cannabis exposure has a
strong geospatial link to LRR which is robust to adjustment for socio
economic and sociodemographic factors. These results are particularly
concerning given prior reports of a wide spectrum of cardiovascular,
neurological and other anomalies reported as being cannabis-related
from various locations including Hawaii, Colorado, Canada, France,
Germany, Switzerland and Australia (Forrester and Merz, 2007; Report
of the Queensland Perinatal Maternal and Perinatal Quality Council and
Queensland Health, 2018; Reece and Hulse, 2019c, 2019d; Robinson,
2019; Reece and Hulse, 2020). We feel that such results should be part of
a program of improved public awareness in relation to the risks asso
ciated with the use of diverse cannabinoids and especially far-reaching
intergenerational implications. Further research into these issues at
both the basic sciences and epidemiological levels is strongly indicated.
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